Schaaf, A., Sagi, S., Langbein, S., Trojan, L., Alken, P., & Michel, M. S. (2004). Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides. Urologic oncology, 22(3), . https://doi.org/10.1016/j.urolonc.2004.01.010
Chicago Style (17th ed.) CitationSchaaf, Axel, Sreedhar Sagi, Sigrun Langbein, Lutz Trojan, Peter Alken, and Maurice Stephan Michel. "Cytotoxicity of Cisplatin in Bladder Cancer Is Significantly Enhanced by Application of Bcl-2 Antisense Oligonucleotides." Urologic Oncology 22, no. 3 (2004). https://doi.org/10.1016/j.urolonc.2004.01.010.
MLA (9th ed.) CitationSchaaf, Axel, et al. "Cytotoxicity of Cisplatin in Bladder Cancer Is Significantly Enhanced by Application of Bcl-2 Antisense Oligonucleotides." Urologic Oncology, vol. 22, no. 3, 2004, https://doi.org/10.1016/j.urolonc.2004.01.010.